Re: RVX's place in therapy - future prediction
in response to
by
posted on
Mar 14, 2021 11:07AM
KOO Very easy answer , DM business management incompetence as well as having the lack any knowledge of increasing shareholder value via getting the consultant help from a major consultant firm has allowed hepalink , oristar , Eastern and other insiders to accumulate as many very cheap shares on insider advantage finance deals without buying on the open market. Can you imagine what the SP would be if a few insiders decided to buy 2 or 3 miilon shares on the open market.... no wonder those insiders wait for DM to finance on the cheap, Those insiders know what Apabetalone can do and its huge potential future potential.. I am still wondering if that BP deal that DM alluded to last fall is floating around . the oristar converting makes me think anything is possible.